ORAMED PHARMACEUTICALS INC.
Ticker: 1176309
P/L Snapshot
Q1 FY25 · consolidated
vs Q2 FY23
Revenue
2.00
+198.5%
Expenditure
6.50
+45.4%
Net Profit
-7.64
-542.0%
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingORMP
202615Sep
Board Meeting
The company held its 2026 Annual Meeting of Stockholders whe…
SEC Filing ↗